Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejection

24 Sept 2024

Abstract excerpt

Donor-derived cell-free DNA (dd-cfDNA) based liquid kidney biopsies have the potential to detect the chances of kidney transplant rejection. Several studies have found that dd-cfDNA can be used to determine the risk of kidney transplant rejection and may correlate with antibody-mediated rejection (ABMR), T cell-mediated rejection (TCMR), and estimated glomerular filtration rate (eGFR). A high concentration of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Organ Donation and Transplantation
Share to Renal Transplantation Outcomes and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39384354
DOI: 10.23876/j.krcp.23.286

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejectionPMID 39384354Read ↗

Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney TransplantSemantic proximity Read ↗

Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft InjuriesSemantic proximity Read ↗

Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter studySemantic proximity Read ↗

Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease StatesSemantic proximity Read ↗

Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation.Semantic proximity Read ↗

The role of donor-derived cell-free DNA in the detection of renal allograft injurySemantic proximity Read ↗

Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection MonitoringSemantic proximity Read ↗

Donor‐derived cell‐free DNA (dd‐cfDNA) for detection of allograft rejection in pediatric kidney transplantsSemantic proximity Read ↗

Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One CenterSemantic proximity Read ↗

Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant MonitoringSemantic proximity Read ↗

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and InfectionSemantic proximity Read ↗

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCRSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.